RT Journal Article
SR Electronic
T1 Tracing and testing the COVID-19 contact chain: cost-benefit tradeoffs
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.01.20205047
DO 10.1101/2020.10.01.20205047
A1 Kim, Jungyeol
A1 Chen, Xingran
A1 Bidokhti, Shirin Saeedi
A1 Sarkar, Saswati
YR 2020
UL http://medrxiv.org/content/early/2020/10/02/2020.10.01.20205047.abstract
AB Traditional contact tracing for COVID-19 tests the direct contacts of those who test positive even if the contacts do not show any symptom. But, why should the testing stop at direct contacts, and not test secondary, tertiary contacts or even contacts further down? The question arises because by the time an infected individual is tested the infection starting from him may have infected a chain of individuals. One deterrent in testing long chains of individuals right away may be that it substantially increases the testing load, or does it? We investigate the costs and benefits of testing the contact chain of an individual who tests positive and discover that it can both substantially reduce the cumulative infection count over time and reduce the testing load over time. We also discover a phenomenon of diminishing return beyond a threshold value on the depth of the chain to be tested in one go, the threshold then provides the most desirable tradeoff between benefit in terms of reducing the cumulative infection count and cost in terms of increasing the testing load.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding sourcesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work does not need any approval of the IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that is used in this study is available from the following paper: Dingqi Yang, Daqing Zhang, Vincent W. Zheng, Zhiyong Yu. Modeling User Activity Preference by Leveraging User Spatial Temporal Characteristics in LBSNs. IEEE Trans. on Systems, Man, and Cybernetics: Systems, (TSMC), 45(1), 129-142, 2015. https://sites.google.com/site/yangdingqi/home/foursquare-dataset